Community

Our community narratives are driven by numbers and valuation.

Value any stock for free in seconds

Get alerts and valuation updates

Participate in discussions

Weekly Picks

Investor

Investingwilly

Community Contributor

The "Boring" Money Printer

Meet Investor AB In a financial world often rocked by inflation, geopolitical shocks, and rapidly changing technology, few companies offer the kind of steady hand that Investor AB does. As Sweden’s largest investment company and a key part of the Wallenberg sphere , Investor AB has shown an unmatched ability to weather economic turbulence – not just for a few years, but for over a century.

View narrative

SEK 350.00

19.4% undervalued

10.79%

Revenue growth p.a.

15 days ago

Bayerische Motoren Werke

Unike

Community Contributor

BMW cruising ahead with new EVs and premium models to boost revenue 5%

Catalysts Most Immediate Catalysts (1–2 Years) Strong EV Expansion: BMW’s iX, i4, and upcoming Neue Klasse EVs are set to drive revenue growth as the EV transition accelerates. Luxury & Premium Market Strength: The high-end market remains resilient, supporting BMW’s strong pricing power and margins.

View narrative

€135.07

43.3% undervalued

5.00%

Revenue growth p.a.

about 1 month ago

Novo Nordisk

Tokyo

Community Contributor

EU#2 - From Humble Beginnings to Global Powerhouse

Novo Nordisk, one of the world’s leading pharmaceutical companies, has a unique and inspiring origin story rooted in personal tragedy and scientific curiosity. The company’s roots date back to the 1920s, when Danish Nobel laureate August Krogh, a renowned physiologist, and his wife Marie, who suffered from type 2 diabetes, traveled to Canada.

View narrative

DKK 851.04

50.1% undervalued

14.00%

Revenue growth p.a.

12 days ago

Load previous narratives

Intuitive Surgical

Unike

Community Contributor

Intuitive Surgical Will Transform Healthcare with 12% Revenue Growth

Catalysts Most Immediate Catalysts (1–2 Years) Increased Adoption of Robotic Surgery: Hospitals and surgical centers continue to adopt Intuitive Surgical’s da Vinci systems as clinical evidence shows improved outcomes and reduced recovery times. Expansion into more surgical specialties (e.g., gynecology, urology, general surgery) drives near-term revenue growth.

View narrative

US$325.55

58.2% overvalued

12.00%

Revenue growth p.a.

about 1 month ago

Thermo Fisher Scientific

Unike

Community Contributor

The demand for personalized medicine will keep Thermo Fisher Scientific thriving

Catalysts Most Immediate Catalysts (1–2 Years) Resilient Demand for Life Sciences & Diagnostics – TMO is a key supplier for biotech, pharma, and research institutions, ensuring steady demand despite economic cycles. Cost Synergies from PPD Acquisition – The 2021 acquisition of PPD (clinical research services) is expected to enhance revenue synergies and margin expansion.

View narrative

US$540.27

20.9% undervalued

7.00%

Revenue growth p.a.

about 1 month ago

Apotea

Unike

Community Contributor

Apotea is poised for growth with its online pharmacy dominance and upcoming market expansions

Catalysts Most Immediate Catalysts (1–2 Years) Online Pharmacy Market Growth: The Swedish pharmacy market is shifting online, benefiting Apotea as the dominant e-commerce player. Consumers increasingly prefer digital purchases over physical store visits.

View narrative

SEK 94.41

17.3% undervalued

7.00%

Revenue growth p.a.

about 1 month ago

Greenwich LifeSciences

White_valkyrie

Community Contributor

Greenwich LifeSciences will eye a valued future at $460 a share, with GP2 leading the way.

*DISCLAIMER: *This article is NOT financial advice of any kind, i am NOT a financial adviser, this content should NOT be construed as an offer, recommendation or inducement to buy or sell Greenwich Lifesciences $GLSI stock. Do yor own Due diligence with this type of products before taking from granted any of these opinions.

View narrative

US$460.00

97.7% undervalued

103.00%

Revenue growth p.a.

about 1 month ago

Catena

Unike

Community Contributor

Catena Logistics Will Thrive with E-commerce Growth as Rents Increase

Catalysts Most Immediate Catalysts (1–2 Years) E-commerce Growth Driving Logistics Demand: Catena’s core business—logistics and warehouse properties—is benefiting from structural growth in e-commerce. As retailers optimize supply chains, demand for modern logistics centers remains high.

View narrative

SEK 229.20

94.5% overvalued

8.00%

Revenue growth p.a.

about 1 month ago

Bayerische Motoren Werke

Unike

Community Contributor

BMW cruising ahead with new EVs and premium models to boost revenue 5%

View narrative

€135.07

43.3% undervalued

5.00%

Revenue growth p.a.

about 1 month ago

Transjamaican Highway

Sean876

Community Contributor

TransJamaican Highway will capitalize on Jamaica's growing tourism sector for consistent revenue

TransJamaican Highway (TJH US): Infrastructure Investment Analysis – March 9, 2025 Company Overview TransJamaican Highway operates Jamaica's critical 50-kilometer East-West toll road network under a concession agreement extending until 2036. Currently trading at US$0.028, the stock offers a 7.5% dividend yield based on consistently growing toll revenues.

View narrative

US$0.03

24.0% undervalued

36.00%

Revenue growth p.a.

about 1 month ago

Digital Realty Trust

Unike

Community Contributor

Digital Realty Trust Will Ride the AI Wave with 7% Revenue Growth

Catalysts Most Immediate Catalysts (1–2 Years) AI & Cloud Demand: Data center demand is booming due to AI, cloud computing, and digital transformation trends. Companies like Microsoft, Google, and Amazon are expanding their hyperscale cloud operations , driving demand for data center capacity.

View narrative

US$110.45

44.7% overvalued

7.00%

Revenue growth p.a.

about 1 month ago

Novo Nordisk

Bejgal

Community Contributor

Novo Nordisk will dominate GLP-1 market with Ozempic and Wegovy growth

Catalysts ◦ Strong position in the GLP-1 drug market , leading with Ozempic for diabetes and Wegovy for obesity. These products have driven significant growth.

View narrative

US$89.59

27.3% undervalued

19.00%

Revenue growth p.a.

113

about 2 months ago

Community

Weekly Picks

The "Boring" Money Printer

BMW cruising ahead with new EVs and premium models to boost revenue 5%

EU#2 - From Humble Beginnings to Global Powerhouse

Intuitive Surgical Will Transform Healthcare with 12% Revenue Growth

The demand for personalized medicine will keep Thermo Fisher Scientific thriving

Apotea is poised for growth with its online pharmacy dominance and upcoming market expansions

Greenwich LifeSciences will eye a valued future at $460 a share, with GP2 leading the way.

Catena Logistics Will Thrive with E-commerce Growth as Rents Increase

BMW cruising ahead with new EVs and premium models to boost revenue 5%

TransJamaican Highway will capitalize on Jamaica's growing tourism sector for consistent revenue

Digital Realty Trust Will Ride the AI Wave with 7% Revenue Growth

Novo Nordisk will dominate GLP-1 market with Ozempic and Wegovy growth

Value any company in seconds

Popular companies

Community

Weekly Picks

The "Boring" Money Printer

BMW cruising ahead with new EVs and premium models to boost revenue 5%

EU#2 - From Humble Beginnings to Global Powerhouse

Community Investing Ideas

Intuitive Surgical Will Transform Healthcare with 12% Revenue Growth

The demand for personalized medicine will keep Thermo Fisher Scientific thriving

Apotea is poised for growth with its online pharmacy dominance and upcoming market expansions

Greenwich LifeSciences will eye a valued future at $460 a share, with GP2 leading the way.

Catena Logistics Will Thrive with E-commerce Growth as Rents Increase

BMW cruising ahead with new EVs and premium models to boost revenue 5%

TransJamaican Highway will capitalize on Jamaica's growing tourism sector for consistent revenue

Digital Realty Trust Will Ride the AI Wave with 7% Revenue Growth

Novo Nordisk will dominate GLP-1 market with Ozempic and Wegovy growth

Value any company in seconds

Popular companies